Drug class
Proteinogenic amino acid; urea-cycle intermediate and nitric-oxide precursor
Mechanism of action
Serves as a substrate for nitric oxide synthase, producing nitric oxide, and as an intermediate in the urea cycle. In urea-cycle disorders, exogenous arginine can support nitrogen disposal by promoting formation of ornithine and downstream urea-cycle intermediates, depending on the specific enzyme defect.
General use cases
- Adjunctive management of selected urea-cycle disorders, including acute hyperammonaemia and chronic management, using formulation- and defect-specific regimens.
- Used in selected mitochondrial disease presentations, including MELAS, under specialist clinical management.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
